Angel Lopez Candales

Researcher

UAMS

Faculty Researcher

2 h-index 17 pubs 10 cited

Research Areas

OverviewAI-generated summary

Angel Lopez Candales' research focuses on cardiovascular disease, particularly within the context of healthcare disparities and the impact of the COVID-19 pandemic. His work includes retrospective analyses of clinical data to understand disease presentation and treatment trends. Recent publications investigate no-show rates in cardiology clinics at safety-net hospitals, the prevalence of specific electrocardiographic changes during the pandemic, and the potential of sodium-glucose transport protein 2 inhibitors for patients with cardiovascular and chronic kidney diseases.

Candales also examines sex differences in cardiovascular disease diagnosis and management and explores physiological metrics like left ventricular apical long-axis length and ejection fraction. His research on heart failure treatment in underserved populations highlights prescription trends for medications like sacubitril/valsartan and SGLT2 inhibitors at safety-net institutions. He has collaborated with researchers at the University of Arkansas for Medical Sciences, including Khalid Sawalha and Aakash Rana.

Metrics

h-index: 2
Publications: 17
Citations: 10

Selected Publications

Left Ventricular Apical Long-Axis Length and Ejection Fraction: A Proof-of-Concept Analysis (2025)

Cureus DOI OpenAlex
A Pilot Study to Analyze the Relationship Between Left Ventricular Systole and Early Diastole: Clues Derived From Longitudinal Mitral Annular Motion (2025)

Cureus DOI OpenAlex
Acute Cardiac Injury and COVID-19 – A Systematic Review and Meta-analysis (2020)

2 citations DOI OpenAlex
Ebstein’s Anomaly in Disguise: Follow the Cues and the Diagnosis Can Be Made (2020)

Cureus 6 citations DOI OpenAlex